A carregar...
Pazopanib and pancreatic toxicity: a case report
BACKGROUND: Pazopanib is an oral multitargeted tyrosine-kinase inhibitor, used as a single agent to treat advanced renal cell carcinoma. Treatment with other tyrosine-kinase inhibitors is known to be associated with asymptomatic elevations of serum amylase and lipase levels. As regards the pazopanib...
Na minha lista:
| Publicado no: | BMC Res Notes |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4434851/ https://ncbi.nlm.nih.gov/pubmed/25967382 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13104-015-1154-4 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|